Zoetis (MEX:ZTS) Valuation Rank


MEX:ZTS Zoetis Inc MEX:ZTS
71 GF Score
Price MXN1,315.20
GF Value MXN3,410.33
Valuation Significantly Undervalued
View Full Analysis

What is Zoetis Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Zoetis Valuation Rank Related Terms

MEX:ZTS
71GF Score
Zoetis Inc MEX:ZTS
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zoetis (MEX:ZTS) Overvalued in 2026?

Based on GuruFocus' analysis, Zoetis stock appears to be undervalued. The current stock price of MXN1,315.20 is trading 61.4% below its estimated GF Value™ of MXN3,410.33. GuruFocus considers Zoetis to be Significantly Undervalued.

Key valuation signals for MEX:ZTS:

  • Valuation Rank:
  • GF Value™: MXN3,410.33 vs. price of MXN1,315.20 (61.4% below fair value)
  • GF Score™: 71/100

No single metric tells the full story. See the MEX:ZTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zoetis Business Description

Address 10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
71GF Score

Get the complete analysis for MEX:ZTS

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,315.20
Price
MXN3,410.33
GF Value